IMR imricor medical systems inc.

Quarterly costs of 2 million (after removing the listing costs)...

  1. 22 Posts.
    lightbulb Created with Sketch. 2
    Quarterly costs of 2 million (after removing the listing costs) and 5 million in the bank. No need for a capital raise until July 2020, that is assuming that we have no sales. The company already has production set up so I would assume half a million sales in quarter 1 and cash flow positive in quarter 2 meaning no capital raise needed? or am i missing something. The product is is in sale-able and approved condition.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.53
Change
-0.055(3.48%)
Mkt cap ! $491.8M
Open High Low Value Volume
$1.58 $1.58 $1.51 $585.9K 382.5K

Buyers (Bids)

No. Vol. Price($)
4 6058 $1.52
 

Sellers (Offers)

Price($) Vol. No.
$1.53 632 2
View Market Depth
Last trade - 14.39pm 17/06/2025 (20 minute delay) ?
IMR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.